================================================================================

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

(Mark One)

[X] QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934

    For the quarterly period ended September 30, 2001

                                       OR

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
    EXCHANGE ACT OF 1934

    For the transition period from ____________ to ____________

                         Commission file number 0-29049


                               RHOMBIC CORPORATION
             (Exact name of registrant as specified in its charter)


         Nevada                                                  86-0824125
(State or other jurisdiction of                               (I.R.S. Employer
incorporation or organization)                               Identification No.)


               11811 N. Tatum Blvd. #3031, Phoenix, Arizona 85028
               (Address of principal executive offices (zip code)


                                 (602) 953-7702
              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) filed all reports  required to
be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of 1934 during
the last 12 months (or for such shorter  period that the registrant was required
to file such reports),  and (2) has been subject to such filing requirements for
the past 90 days. Yes [X]   No [ ]

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common equity, as of the latest practicable date.

            Class                                   Outstanding at June 30, 2001
            -----                                   ----------------------------
Common Stock, par value $0.001                               28,392,242

================================================================================
<PAGE>
                          PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENT

                               RHOMBIC CORPORATION
                          (A Development Stage Company)

                           CONSOLIDATED BALANCE SHEET
                               September 30, 2001
                                   (Unaudited)

                                     ASSETS
CURRENT ASSETS:
  Cash                                                              $     1,593
  Prepaid Expenses                                                          600
                                                                    -----------
        Total Current Assets                                              2,193
                                                                    -----------
OTHER ASSETS:
  Investments                                                            41,995
  Licensing Agreements and Technologies                                 581,257
  Patents                                                               102,095
                                                                    -----------

        Total Assets                                                $   727,540
                                                                    ===========

                                  LIABILITIES

CURRENT
  Accounts Payable                                                  $    52,646
                                                                    -----------
                                                                         52,646
STOCKHOLDERS' EQUITY
  Preferred Stock, $.001 Par Value, 1,000,000 Shares Authorized,
   None Issued
  Common Stock, $.001 Par Value, 70,000,000 Shares Authorized,
   28,392,242 Issued and Outstanding                                     28,392
  Additional Paid-in Capital                                          8,402,969
  (Deficit) Accumulated During the Development Stage                 (7,756,467)
                                                                    -----------

        Total Stockholders' Equity                                      674,894
                                                                    -----------

        Total Liabilities and Stockholders' Equity                  $   727,540
                                                                    ===========

                 SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS

                                       2
<PAGE>
                               RHOMBIC CORPORATION
                          (A Development Stage Company)

                      CONSOLIDATED STATEMENTS OF OPERATIONS
                                  (Unaudited)

<TABLE>
<CAPTION>
                                              For the 9 Months Ended              For the 3 Months Ended       Cummulative From
                                         -------------------------------     -------------------------------   November 21, 1994
                                         Sept 30, 2001     Sept 30, 2000     Sept 30, 2001     Sept 30, 2000    to Sept 30,2001
                                         -------------     -------------     -------------     -------------    ---------------
<S>                                       <C>               <C>               <C>               <C>               <C>
ROyalty Income                            $        --       $        --       $        --       $        --       $     5,729
Interest Income                                    80             4,832                --             2,330             6,955
                                          -----------       -----------       -----------       -----------       -----------
                                                   80             4,832                --             2,330            12,684
EXPENSES
  Research and Development Expense             12,246           388,854             6,465            66,196           697,835
  Write Down of Intellectual Property              --                --                --                --         1,487,630
  Legal & Accounting                          116,521           234,319            46,093            65,566           693,783
  Transfer Agent Expenses                         948             4,460               519                --            26,208
  Consulting, Related Party                        --            60,000                --            15,000           367,000
  Consulting                                   37,375           328,453            36,500           276,158         3,091,255
  Interest Expense                              2,917                --                --                --             2,917
  Other General & Administrative              257,170           874,627            72,561             4,787         1,309,907
                                          -----------       -----------       -----------       -----------       -----------
        Total Expenses                        427,177         1,890,713           162,138           427,707         7,676,535
                                          -----------       -----------       -----------       -----------       -----------

Loss before other expenses                    427,097         1,885,881           162,138           425,377         7,663,851

OTHER EXPENSES
  Loss on Sale of Marketable Securities        92,616                --            92,616                --            92,616
                                          -----------       -----------       -----------       -----------       -----------
NET (LOSS)                                $  (519,713)      $(1,885,881)      $  (254,754)      $  (425,377)      $(7,756,467)
                                          ===========       ===========       ===========       ===========       ===========
NET LOSS PER SHARE:
  Basic                                   $     (0.02)      $     (0.06)      $     (0.00)      $     (0.01)
                                          ===========       ===========       ===========       ===========
  Diluted                                 $     (0.02)      $     (0.06)      $     (0.00)      $     (0.01)
                                          ===========       ===========       ===========       ===========
WEIGHTED AVERAGE SHARES OUTSTANDING:
  Basic                                    26,772,481        34,484,813        26,772,481        34,484,813
                                          ===========       ===========       ===========       ===========
  Diluted                                  26,772,481        34,384,813        26,772,481        34,484,813
                                          ===========       ===========       ===========       ===========
</TABLE>

                 SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS

                                       3
<PAGE>
                               RHOMBIC CORPORATION
                          (A Development Stage Company)

           CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                                                 (Deficit)
                                                                                                Accumulated
                                                           Common Stock          Additional       During
                                                      ----------------------      Paid-in       Development
                                                        Shares       Amount       Capital          Stage         Total
                                                        ------       ------       -------          -----         -----
<S>                                                   <C>          <C>           <C>            <C>            <C>
Balance at December 31, 1999                          24,741,100   $  24,741    $ 4,589,750    $(2,078,855)    $2,535,636
  Acquisition of Intellectual Property                   100,000         100        281,150                       281,250
  Shares Issued to Acquire Emerald Investments           200,000         200           (200)
  Shares Issued for Services                              75,000          75        214,350                       214,425
  Exercise of Stock Options                              170,000         170        107,080                       107,250
  Net Loss for the Quarter Ended March 31, 2000                                                   (604,944)      (604,944)
                                                     -----------   ---------    -----------    -----------     ----------

Balance At March 31, 2000                             25,286,100      25,286      5,192,130     (2,683,799)     2,533,617
  Acquisition of Intellectual Property                   100,000         100        194,150                       194,250
  Shares Issued for Services                             350,000         300        661,066                       661,416
  Net Loss for the Quarter Ended June 30, 2000                                                    (855,460)      (855,460)
                                                     -----------   ---------    -----------    -----------     ----------

Balance At June 30, 2000                              25,736,100      25,736      6,047,346     (3,539,259)     2,533,823
  Adjustment for Shares Issued for Services                                         (40,188)                      (40,188)
  Shares Issued for Services                             350,000         350        272,650                       273,000
  Exercise of Stock Options                              200,000         200        199,800                       200,000
  Net Loss for the Quarter Ended Sepember 30, 2000                                                (425,377)      (425,377)
                                                     -----------   ---------    -----------    -----------     ----------

Balance At September 30, 2000                         26,286,100   $  26,286    $ 6,479,608    $(3,964,636)    $2,541,258
                                                     ===========   =========    ===========    ===========     ==========

Balance at December 31, 2000                          26,286,100   $  26,286    $ 8,043,540    $(7,236,754)    $  833,072
  Shares issued for services                             290,000         290         59,710                        60,000
  Net loss for the quarter ended March 31, 2001                                                   (144,255)      (144,255)
                                                     -----------   ---------    -----------    -----------     ----------

Balance at March 31, 2001                             26,576,100      26,576      8,103,250     (7,381,009)       748,817
  Shares issued for services                             400,000         400         91,600                        92,000
  Shares issued for debenture conversion               1,166,142       1,166        198,834                       200,000
  Costs of offering                                                                 (20,831)                      (20,831)
  Net loss for the quarter ended June 30, 2001                                                    (120,704)      (120,704)
                                                     -----------   ---------    -----------    -----------     ----------

Balance at June 30, 2001                              28,142,242      28,142      8,372,853     (7,501,713)       899,282
  Shares issued for services                             250,000         250         31,250                        31,500
  Costs of offering                                                                  (1,134)                       (1,134)
  Net loss for the quarter Sept. 30, 2001                                                         (254,754)      (254,754)
                                                     -----------   ---------    -----------    -----------     ----------

 Balance at September 30, 2001                        28,392,242   $  28,392    $ 8,402,969    $(7,756,467)    $  674,894
                                                     ===========   =========    ===========    ===========     ==========
</TABLE>

                 SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS

                                       5
<PAGE>
                               RHOMBIC CORPORATION
                          (A Devlopment Stage Company)

                      CONSOLIDATED STATEMENTS OF CASH FLOW
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                            For the Nine Months         For the Three Months     Cumulative From
                                                               Ended Sept 30,              Ended Sept 30,       November 21, 1994
                                                            -------------------         --------------------     (Inception) to
                                                            2001           2000         2001            2000      Sept 30, 2001
                                                            ----           ----         ----            ----      -------------
<S>                                                    <C>            <C>           <C>            <C>            <C>
OPERATING ACTIVITIES
  Net (Loss) Income for the Period                        $(519,713)   $(1,885,781)  $  (254,754)  $  (425,377)    $(7,756,467)
  Adjustments to Reconcile Net Cash Used by Operations:
    Write Down of Intellectual Property                          --             --            --            --       1,487,630
    Marketable Securities Exchanged for Services             35,820             --        35,820            --          35,820
    Marketable Securities Exchanged for Payables             27,818             --        27,818            --          27,818
    Loss On Sale of Marketable Securities                    92,617             --        92,617            --          92,617
    Common Stock Issued for Services                        183,500      1,108,653        31,500       232,812       1,892,484
    Fair Value of Options Granted                                --             --            --            --       2,082,113
    (Increase) Decrease in Accounts Receivable                   --         15,103           291            --              --
    (Increase) Decrease in Prepaid Expenses                   1,900        116,855           400        38,748            (600)
    Increase (Decrease) in Accounts Payable                 (63,909)        72,826        17,915        73,390          52,646
    Increase (Decrease) in Due to Related Parties                --          3,793            --       (14,826)             --
                                                          ---------    -----------   -----------   -----------     -----------
        Net Cash (Used) by Operating Activities            (241,967)      (568,551)      (48,393)      (95,253)     (2,085,939)
                                                          ---------    -----------   -----------   -----------     -----------
FINANCING ACTIVITIES
  Proceeds From Private Placements                               --             --            --            --       1,266,629
  Proceeds From Convertible Debenture                       200,000             --            --            --         200,000
  Offering Costs                                            (21,965)            --        (1,134)           --         (21,965)
  Proceeds From Exercise of Stock Options                        --        307,250            --       200,000       1,006,750
  Proceeds From Sale of Marketable Securities                19,506             --        19,506            --          19,506
                                                          ---------    -----------   -----------   -----------     -----------
        Cash Provided From Financing Activities             197,541        307,250        18,372       200,000       2,470,920
                                                          ---------    -----------   -----------   -----------     -----------
INVESTING ACTIVITIES
   Cost of Patents                                          (47,365)       (52,257)           --       (43,941)       (165,632)
   Investment in Marketable Securities                           --             --            --            --        (217,756)
                                                          ---------    -----------   -----------   -----------     -----------
        Cash Used in Investment Activities                  (47,365)       (52,257)           --       (43,941)       (383,388)
                                                          ---------    -----------   -----------   -----------     -----------

Increase in Cash                                            (91,791)      (313,558)      (30,021)      (60,806)          1,593
Cash at Beginning of Period                                  93,384        557,553        31,614       183,189              --
                                                          ---------    -----------   -----------   -----------     -----------
Cash at End of Period                                     $   1,593    $   243,995   $     1,593   $   243,995     $     1,593
                                                          =========    ===========   ===========   ===========     ===========

Interest Expense                                          $   2,917    $        --   $        --   $        --     $     2,917

SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND
FINANCING ACTIVITIES
Issuance of Common Stock for Licensing Agreements
 and Technologies                                         $      --    $   475,500   $        --   $        --     $ 2,005,530
</TABLE>

                 SEE ACCOMPANYING NOTES TO FINANCIAL STATEMENTS

                                       6
<PAGE>
                               RHOMBIC CORPORATION
                          (A Development Stage Company)

                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
               for the Quarters Ended Ended June 30, 2001 and 2000


     The unaudited  financial  statements included herein were prepared from the
records  of  the  Company  in  accordance  with  Generally  Accepted  Accounting
Principles. These financial statements reflect all adjustments which are, in the
opinion of  management,  necessary to provide a fair statement of the results of
operations  and  financial  position  for the interim  periods.  Such  financial
statements  generally  conform to the  presentation  reflected in the  Company's
Forms 10-KSB and 10-KSB filed with the  Securities  and Exchange  Commission for
the year ended December 31, 2000. The current  interim  period  reported  herein
should  be read in  conjunction  with  the  Company's  Form  10-KSB  subject  to
independent audit at the end of the year.

     The results of operations for the three months ended September 30, 2001 are
not  necessarily  indicative  of the results  that may be expected  for the year
ending December 31, 2001.

CONVERTIBLE DEBENTURE

     On March 8, 2001, Rhombic signed a convertible  debenture for $2.5 million.
The Holder  funded  $200,000 on the  debenture  and  converted the advances into
1,166,142  shares of the Company under the terms of the  debenture.  On July 20,
2001, the Company withdrew its registration  statement for the shares issued and
to be issued  under the  debenture  because it was no longer  applicable  to the
Company.  A new  registration  statement was filed on October 2, 2001 which will
register all shares that were sold under the debenture.

STOCKHOLDERS' EQUITY

     During the third quarter of 2001,  the Company  issued  250,000  restricted
common shares as payment in full for consulting services regarding financing for
the company. The transaction had a deemed value of $ 31,500.

     The deemed  value of the all shares  issued was  determined  based upon the
trading value of the  Company's  common stock at the time of the issuance of the
stock.

SUBSEQUENT EVENTS

     On  November 5, 2001,  the Company  entered  into a  non-binding  letter of
intent with Famco Holding Company,  LLC to reach a definitive  agreement wherein
Rhombic  would  acquire  all the  outstanding  shares  of six  corporations  for
approximately 630,000,000 common shares of Rhombic,  restricted pursuant to Rule
144, and resulting in a change of control.  It is anticipated that the operating
corporations will be acquired individually over a four to six month period after
due diligence and audited  financial  statements  are  completed.  The unaudited
revenues from two of the operating  companies last year approximated $12 million
with income before taxes of $4.4 million.  Other companies are in a research and
development phase and will be sold to Rhombic upon completion of the development
phase and a readiness to commence sales. Upon the satisfactory completion of due
diligence,  the  directors of Rhombic will  recommend  the  acquisitions  to the
shareholders with the specific terms.

                                       7
<PAGE>
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF OPERATION

PLAN OF OPERATION

The  following  discussion  is intended to provide an analysis of the  Company's
financial condition and Plan of Operation and should be read in conjunction with
the Company's financial  statements and the notes thereto. The matters discussed
in this section that are not  historical or current  facts,  deal with potential
future circumstances and developments.  Such forward-looking statements include,
but are not  limited  to,  the  development  plans for the  technologies  of the
Company,  trends  in the  results  of  the  Company's  development,  anticipated
development  plans,  operating  expenses and the Company's  anticipated  capital
requirements  and capital  resources.  The Company's actual results could differ
materially from the results discussed in the forward-looking statements.

The Company has not  generated  revenue  from  operations  during the first nine
months of 2001 or since its  inception.  During the third  quarter of 2001,  the
Company began the quarter with $31,614 in cash. At November 1, 2001, the Company
had a working capital deficit. The Company had approximately $29,000 in cash and
trade payables of approximately $42,500 at that date.

During the third  quarter of this year,  the company sold 600,000  shares of its
holdings in Rockford  Technology  Corporation  for $19,506 in cash and exchanged
900,000  shares of Rockford for  services and the payment of existing  payables.
The Company  disbursed  approximately  $10,000 in cash for  auditor  reviews and
legal fees regarding the registration  statement,  quarterly filing and business
consulting,  $5,000 to a scientific consultant for an opinion on current patents
and  patents  pending as well as $ 35,000  for  salaries,  travel  and  overhead
expenses.

Subsequent to September 30, 2001, the Company received  approximately $36,700 in
cash from the sale of most of its marketable  securities from which it dispersed
$ 20,646 for payables existing at September 30, 2001. The Company also satisfied
payables  at  September  30,  2001 of $ 22,000 by issuing  common  shares to the
previous President.

In early July 2001, the Company terminated its investor relation  representative
and hired a  scientific  consultant  to  evaluate  all of the patents and patent
applications of the Company for relevance to potential commercial  applications.
The consultant first stated that all patents and provisional  patents  involving
Field Enhanced  Diffusion by Optical  Activation  (FEDOA) which covered  diamond
based fuel cells, diamond doping and the removal of impurities, listed inventors
that are or were faculty members of the University of Missouri at Columbia.  The
University  Administration asserts that all inventions created at the University
by its faculty  members are its  intellectual  property and not  Rhombic's.  The
following opinions on Rhombic's  provisional patents invented by faculty members
at the University of Missouri are summarized as follows:

     1.   Provisional  patents for the System and Method for Diamond  Based Fuel
          Cells give substantial evidence that the described process using FEDOA
          is too slow to be economically feasible.

     2.   Provisional  patent  applications  covering  the doping of natural and
          chemically vacuum deposited (CVD) diamond using FEDOA is too slow of a
          process  to  be  economically   feasible.   Additional  research  into
          electrical  applications  of these  provisional  patents could be used
          with  other   doping   processes  to  explore   potential   commercial
          applications.

     3.   Provisional patent applications for a System and Method for Removal of
          Imputities  from  materials such as  semiconductors  using FEDOA would
          require  significantly  more research to determine  commercial  value.
          Although  the  process  appears  to offer an  increase  yield of chips
          obtainable  from wafers,  the  commercial  viability  is  questionable
          because the FEDOA is very slow for commercial applications.

                                       8
<PAGE>
     4.   Provisional  patent  applications  for  Carbon  Crystal  Growth  Using
          Electric  Emission  Enhanced  Showerhead  Hot Filament  Chemical Vapor
          Deposition  offers an improved  process for the CVD  process,  but the
          applications  and  inventors  do not  have  enough  data to  determine
          commercial viability.

The  conclusion of the consultant and the company was not to continue the patent
process of the above listed provisional patent  applications  because of (1) the
limited economic  viability due primarily to the process speed of FEDOA; (2) the
high costs of patent counsel and the direct costs to obtain domestic and foreign
patents; and (3) the potential exposure to royalty payments to the University of
Missouri with corresponding costs of defending ownership of the patents.

The  consultant  also  evaluated  Rhombic's   intellectual   property  that  was
unaffected by potential claims from the University of Missouri. His opinions are
as follows:

     1.   Provisional  patent  for  the  Method  and  System  for  Manufacturing
          Disperse Composite Materials is of great economic value if the process
          is fully  developed  for the  numerous  applications  that  are  being
          proposed now by industry or that will emerge shortly.

     2.   Provisional  patent for a Method of Contact Diffusion into Diamond and
          Other Crystalline  Structures and Products using its thermal diffusion
          method is commercially viable.

The consultant  recommended  proceeding  with a development  plan for commercial
applications  involving the Manufacturing of Disperse  Composite  Materials.  He
also  recommended  to proceed with Contact  Diffusion into Diamond if reasonable
arrangements  could be made to secure a license to receive the processed diamond
material necessary to complete the process.

Upon the  recommendations  of the  consultant,  the  company met with its patent
attorneys and determined  that the  application  deadlines to extend the patents
pending on the Manufacturing of Disperse Composite  Materials had expired.  As a
result,  the President  met with the  inventors of the patents and  determined a
commitment  of $ 500,000 to  $1,000,000  in  capital  would be needed to begin a
development program for any commercial  applications that would provide specific
patent coverage for any process  developed.  Due to existing  financing problems
that the Company was facing,  Rhombic's  President  recommended  a merger with a
private  research  and  development  company  that had capital  and  scientists.
Unfortunately,  Rhombic never received  enough  information  from the company to
evaluate a merger and Rhombic's President subsequently resigned.

The  Company  does not have any  employees  and  uses  consultants  for  matters
pertaining  to  coordinating  technology  development  and  administration.  The
Company may hire  employees  during the next twelve  months  depending  upon its
success  in  developing  prototype  applications  for  sale and  financing  more
development.

This report contains  forward-looking  statements  within the meaning of Section
27A of the  Securities Act of 1933, and Section 21E of the Exchange Act of 1934.
Although  the  Company   believes  that  the   expectations   reflected  in  the
forward-looking  statements and the assumptions  upon which the  forward-looking
statements  are  based  are  reasonable,  it can  give no  assurance  that  such
expectations and assumptions will prove to be correct.

                                       9
<PAGE>
                          PART II -- OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

     There are no legal  proceedings  against  the  Company  and the  Company is
unaware of any proceedings contemplated against it.

ITEM 2. CHANGES IN SECURITIES

     The  following  information  is  given  with  respect  to all  unregistered
securities sold or issued by Rhombic in the period covered by this report:

     (1) On August 9, 2001  25,000  restricted  common  shares  were issued to a
consultant  regarding financing for the Company.  The deemed value of the shares
issued was $4,500  which was  determined  based  upon the  trading  value of the
Company's  common  stock  at the  time  of the  issuance  of the  stock  and the
agreement.  These  shares were issued by the Company  pursuant to the  exemption
found in Section 4(2)of the Securities Act of 1933.

     (2) On September 13, 2001,  the Company issued  175,000  restricted  common
shares of its common stock to two financial  consultants regarding financing for
the Company and 50,000 restricted common shares to a scientific consultant.  The
deemed value of the shares  issued was $27,000 which was  determined  based upon
the trading value of the  Company's  common stock at the time of the issuance of
the stock and the agreement. These shares were issued by the Company pursuant to
the exemption found in Section 4(2)of the Securities Act of 1933.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

     Not applicable.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

     Not applicable.

ITEM 5. OTHER INFORMATION

     On  November 5, 2001,  the Company  entered  into a  non-binding  letter of
intent with Famco Holding Company,  LLC to reach a definitive  agreement wherein
Rhombic  would  acquire  all the  outstanding  shares  of six  corporations  for
approximately 630,000,000 common shares of Rhombic,  restricted pursuant to Rule
144, and resulting in a change of control.  It is anticipated that the operating
corporations will be acquired individually over a four to six month period after
due diligence and audited  financial  statements  are  completed.  The unaudited
revenues from two of the operating  companies last year approximated $12 million
with income before taxes of $4.4 million.  Other companies are in a research and
development phase and will be sold to Rhombic upon completion of the development
phase and a readiness to commence sales. Upon the satisfactory completion of due
diligence,  the  directors of Rhombic will  recommend  the  acquisitions  to the
shareholders with the specific terms.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

     (a) Exhibits

         None

     (b) Reports on Form 8-K

     During the quarter  ended  September  30, 2001,  the Company did not file a
Form 8-K.  Subsequent to the end of the quarter,  the Company filed one Form 8-K
report.  The report was filed on October 12, 2001 and is incorporated  herein by
reference.  The  report  disclosed  the  resignation  of Roger  Duffield  as the
President and a director of the Company.

                                       10
<PAGE>
                                   SIGNATURES

     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                        RHOMBIC CORPORATION

                                        By: /s/ Albert Golusin
                                            ------------------------------------
Date: November 14, 2001                     Albert Golusin
                                            Chief Financial Officer

                                       11